Zobrazeno 1 - 10
of 62
pro vyhledávání: '"Joey Junarta"'
Autor:
Muhammad U. Siddiqui, Eric Warner, Joey Junarta, Parker O’Neill, David Signarovitz, Eyad Kanawati, Mohammed Murtaza, David Fischman
Publikováno v:
Journal of Interventional Cardiology, Vol 2024 (2024)
Background. Studies have demonstrated poor prognosis in cancer patients who undergo percutaneous coronary intervention (PCI) for coronary artery disease (CAD). Cancer patients receiving PCI are at increased risk of in-stent thrombosis, bleeding, hosp
Externí odkaz:
https://doaj.org/article/32a6286d8f8b4ccdbdd7e94f03466013
Autor:
Muhammad U. Siddiqui, Joey Junarta, Joshua M. Riley, Adnan Ahmed, Ahmed K. Pasha, Kolin Limbrick, Rene J. Alvarez, Daniel R. Frisch
Publikováno v:
Journal of Arrhythmia, Vol 38, Iss 6, Pp 981-990 (2022)
Abstract Background Catheter ablation for atrial fibrillation (AF) is a proven alternative to pharmacologic rhythm control in patients with heart failure with reduced ejection fraction (HFrEF). Whether outcomes differ in patients with heart failure w
Externí odkaz:
https://doaj.org/article/f7ed2eacc0b14332a2ed85e16d2d9627
Autor:
Joey Junarta, Sean J. Dikdan, Naman Upadhyay, Andrea Molin, Sairamya Bodempudi, Eric Warner, Daniel Joffe, Zachary Pang, Daniel R. Frisch
Publikováno v:
Journal of Arrhythmia, Vol 38, Iss 4, Pp 589-597 (2022)
Abstract Background The value of additional ablation beyond pulmonary vein isolation for atrial fibrillation (AF) ablation is unclear, especially for persistent AF. It is uncertain whether substrate modification with additional extensive ablation imp
Externí odkaz:
https://doaj.org/article/8398b456c1e048478cf55498726c2ab8
Autor:
Muhammad U. Siddiqui, Joey Junarta, Swaminathan Sathyanarayanan, Kirpal Kochar, Waqas Ullah, David L. Fischman
Publikováno v:
International Journal of Cardiology: Heart & Vasculature, Vol 45, Iss , Pp 101191- (2023)
Background: Colchicine has anti-inflammatory properties, but its utility in improving cardiovascular outcomes has been disputed. Here, we study the impact of colchicine on cardiovascular outcomes in patients with gout with and without coronary artery
Externí odkaz:
https://doaj.org/article/b40fb5696131435580c3bbc4d057c9ac
Autor:
Muhammad Umer Siddiqui, Omar Yacob, Joey Junarta, Ahmed K. Pasha, Farouk Mookadam, Mamas A. Mamas, David L. Fischman
Publikováno v:
BMC Cardiovascular Disorders, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Background With advancements in cancer treatment, the life expectancy of oncology patients has improved. Thus, transcatheter aortic valve replacement (TAVR) may be considered as a feasible option for oncology patients with severe symptomatic
Externí odkaz:
https://doaj.org/article/ae9c2d604baa4c8e887532bd602fae72
Publikováno v:
Journal of Arrhythmia, Vol 37, Iss 4, Pp 893-898 (2021)
Abstract Introduction Myriad cardiovascular manifestations have been reported with COVID‐19. We previously reported that failure of PR interval shortening with increasing heart rate (HR) in patients with COVID‐19 is associated with adverse outcom
Externí odkaz:
https://doaj.org/article/ae23639842d34fb1b09f910dca512566
Autor:
Joey Junarta, Gregary D. Marhefka
Publikováno v:
Annals of Noninvasive Electrocardiology, Vol 27, Iss 4, Pp n/a-n/a (2022)
Abstract The patient is a 73‐year‐old female with peripheral vascular disease, coronary artery disease, and systemic lupus erythematosus, who underwent mesenteric artery bypass surgery. She suffered from a pneumonia after surgery, causing acute h
Externí odkaz:
https://doaj.org/article/103ad59fcd7940a0bac805f1d69620b6
Publikováno v:
BMC Cardiovascular Disorders, Vol 20, Iss 1, Pp 1-7 (2020)
Abstract Background Kidney transplant patients suffer from vascular abnormalities and high cardiovascular event rates, despite initial improvements post-transplantation. The nature of the progression of vascular abnormalities in the longer term is un
Externí odkaz:
https://doaj.org/article/dea9c61ac31a4a96af6f009041cb4b2e
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 4 (2022)
Background Coronary artery disease (CAD) is highly prevalent in patients with chronic kidney disease and is a common cause of mortality in end‐stage renal disease. Thus, patients with end‐stage renal disease are routinely screened for CAD before
Externí odkaz:
https://doaj.org/article/f414216aca364e9eb5e417ca6f497ba6
Autor:
Joey Junarta, Muhammad U Siddiqui, Joshua M Riley, Sean J Dikdan, Akash Patel, Daniel R Frisch
Publikováno v:
EP Europace. 24:1585-1598
Aims The value of additional ablation beyond pulmonary vein isolation for atrial fibrillation (AF) ablation is unclear, especially for persistent AF. The optimal target for substrate modification to improve outcomes is uncertain. We investigate the u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a476162edaf10af51e6a0afed44a782f
https://doi.org/10.1093/europace/euac089
https://doi.org/10.1093/europace/euac089